Invention Grant
- Patent Title: Method for treatment of osteoarthritis with C-Fms antagonists
-
Application No.: US14970578Application Date: 2015-12-16
-
Publication No.: US10005840B2Publication Date: 2018-06-26
- Inventor: Stefan Steidl , John Allan Hamilton , Andrew David Cook
- Applicant: The University of Melbourne , MorphoSys AG
- Applicant Address: DE Planegg AU Parkville
- Assignee: MORPHOSYS AG,THE UNIVERSITY OF MELBOURNE
- Current Assignee: MORPHOSYS AG,THE UNIVERSITY OF MELBOURNE
- Current Assignee Address: DE Planegg AU Parkville
- Agency: Licata & Tyrrell P.C.
- Priority: EP11174305 20110718
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/00 ; C07K16/24 ; C07K16/38 ; C07K16/28
Abstract:
The present invention relates generally to a method for the treatment and/or prophylaxis of osteoarthritis (OA) and/or pain. In accordance with the present invention, an antagonist of c-Fms is effective in the treatment of osteoarthritis and/or pain. An antagonist of M-CSF includes, but is not limited to, an antibody that is specific for M-CSF, IL-34 or c-Fms.
Public/Granted literature
- US20160185867A1 Use of c-Fms antagonists Public/Granted day:2016-06-30
Information query
